New pill tested to fight debilitating long COVID
Disease control
Completed
This study tested an oral medication called LAU-7b to see if it could reduce the burden of Long COVID. It involved 272 adults with moderate to severe Long COVID symptoms, comparing the drug against a placebo over 12 weeks. The main goal was to see if the treatment improved patien…
Phase: PHASE2, PHASE3 • Sponsor: Laurent Pharmaceuticals Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:41 UTC